OSL:MEDI • NO0010159684
The current stock price of MEDI.OL is 213 NOK. In the past month the price decreased by -9.75%. In the past year, price increased by 33.13%.
ChartMill assigns a technical rating of 1 / 10 to MEDI.OL. When comparing the yearly performance of all stocks, MEDI.OL turns out to be only a medium performer in the overall market: it outperformed 52.96% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to MEDI.OL. MEDI.OL has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company.
Over the last trailing twelve months MEDI.OL reported a non-GAAP Earnings per Share(EPS) of 7.79. The EPS increased by 40.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 21.3% | ||
| ROA | 24.76% | ||
| ROE | 34.02% | ||
| Debt/Equity | 0.05 |
7 analysts have analysed MEDI.OL and the average price target is 265.2 NOK. This implies a price increase of 24.51% is expected in the next year compared to the current price of 213.
For the next year, analysts expect an EPS growth of 16.97% and a revenue growth 17.55% for MEDI.OL
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 16.09 | 108.279B | ||
| 2M6 | MEDTRONIC PLC | 15.76 | 107.061B | ||
| SHL | SIEMENS HEALTHINEERS AG | 15.7 | 46.868B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 17.48 | 25.344B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 17.46 | 25.315B | ||
| BIM | BIOMERIEUX | 19.08 | 11.209B | ||
| DIA | DIASORIN SPA | 17.12 | 3.929B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 18.29 | 3.599B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 11.25 | 2.372B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 10.94 | 2.309B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
MEDISTIM ASA
Okernveien 94
Oslo OSLO NO
Employees: 154
Phone: 4723059660
Medistim ASA engages in the development, manufacture, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo and currently employs 154 full-time employees. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The firm provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
The current stock price of MEDI.OL is 213 NOK. The price decreased by -0.47% in the last trading session.
MEDISTIM ASA (MEDI.OL) has a dividend yield of 2.93%. The yearly dividend amount is currently 4.5.
MEDI.OL has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
MEDI.OL stock is listed on the Euronext Oslo exchange.
7 analysts have analysed MEDI.OL and the average price target is 265.2 NOK. This implies a price increase of 24.51% is expected in the next year compared to the current price of 213.
MEDISTIM ASA (MEDI.OL) has a market capitalization of 3.91B NOK. This makes MEDI.OL a Mid Cap stock.